Why Is Chemring Group PLC Up Today?

Chemring Group PLC shares rose 0.85% today, according to the market data provided, continuing a strong run for the UK defence and security manufacturer.

There is no single new announcement fully explaining today's move, but Chemring has been a consistent beneficiary of rising NATO and allied defence spending, reflected in a record order book disclosed across recent trading updates.

The Company's H1 2026 results showed a record order book of £1.4 billion, up 8%, even as adjusted operating profit dipped due to near-term UK market disruption.

Key Highlights

Chemring's H1 2026 results, covering the six months to 30 April, showed revenue up 7% to £237 million, with the order book up 8% to a record £1.4 billion.

Adjusted operating profit fell 8% to £24.5 million, impacted by lower-than-expected activity at Roke and pre-production costs for the Cortexa counter-drone system.

Around 91% of expected 2026 Revenue was already covered by the order book as of late April, up from 85% earlier in the year, providing strong forward visibility.

About Chemring Group PLC

Chemring Group PLC is a key contributor to the defence industrial base, supplying materials, subsystems, components and technologies into growing areas of defence, security and space markets.

The Group operates through Countermeasures & Energetics (C&E) and Sensors & Information (S&I) sectors, including its specialist cyber and intelligence Subsidiary Roke.

Founded in 1905 and headquartered in Romsey, Hampshire, Chemring has an ambition to double annual revenue to £1 billion by 2030.

Key Reasons Behind Today's Rise

Today's 0.85% gain reflects continued investor confidence in Chemring's record order book, providing excellent medium-term revenue visibility.

Chief Executive Michael Ord has repeatedly highlighted that 'growing geopolitical uncertainty is driving increased expenditure' across NATO and allied target markets, a theme resonating strongly with investors.

Recent contract wins, including a £22.5 million STORM Missile Defence Centre order for Roke, have reinforced confidence in the Sensors & Information division's recovery.

Order Book Strength And Segment Performance

The Countermeasures & Energetics sector's FY26 revenue is now 96% covered by revenue generated to date and the current order book, reflecting exceptionally strong visibility.

Chemring Countermeasures UK won contracts from a range of NATO and non-NATO customers totalling £55 million for airborne and naval countermeasures, with deliveries scheduled through FY26-FY29.

In the Sensors & Information sector, Roke has continued to make progress on key strategic activities, receiving around £45 million of new orders including the STORM Missile Defence Centre contract.

Growth Catalysts

The clearest catalyst for Chemring is continued rising defence spending across NATO and allied nations, which management expects to persist well into the next decade.

Significant ongoing Investment in growing Energetics capacity positions the Group to capture further Demand as production expands.

Progress toward the Group's ambition of doubling annual revenue to £1 billion by 2030 could support continued re-rating if execution remains on track.

Risks

The primary risk for Chemring is near-term operational disruption, as seen in countermeasures production issues and softer Roke activity affecting H1 2026 profitability.

Order intake can be lumpy and dependent on large multi-year contract timing, as illustrated by a sharp decline in Q1 FY26 order intake against a strong prior-year comparator.

A planned transfer of Kilgore Flares' legacy operations to a new automated facility is expected to lead to a non-cash Impairment charge.

Wider Market Backdrop

Global defence spending has risen sharply amid heightened geopolitical tensions, including conflict in Ukraine and instability across the Middle East, both cited as demand drivers for Chemring's products.

The UK's Defence Investment Plan, including an extra £15 billion in spending announced by the government, has been highlighted by markets as a broader tailwind for UK defence stocks.

Continued global security uncertainty is likely to sustain elevated NATO and allied defence budgets, supporting Chemring's medium-term order book visibility.

Valuation

Chemring shares have performed strongly over the past year, up around a third, reflecting sustained investor enthusiasm for UK defence names amid rising global military spending.

With a record order book and 91% revenue cover for FY26, the Company's valuation reflects genuine forward Earnings visibility rather than speculative growth assumptions.

The shares' performance has broadly tracked that of larger UK defence peers such as BAE Systems, reflecting sector-wide re-rating.

What Investors Should Watch Next

Investors should watch continued order book growth and revenue cover trends across both Countermeasures & Energetics and Sensors & Information sectors.

Progress on the Cortexa counter-drone system launch and its transition from pre-production costs to revenue generation will be important.

UK Defence Investment Plan implementation and broader NATO spending commitments will remain relevant to Chemring's order pipeline.

Conclusion

Chemring continues to benefit from a structural increase in global defence spending, reflected in a record order book even as near-term operational disruptions have weighed on H1 profitability.

Today's 0.85% rise reflects sustained investor confidence in this multi-year growth story.

The key question ahead will be whether Chemring can resolve near-term operational challenges at Roke and its countermeasures facilities while continuing to convert its record order book into profit growth.